Back
Neurocrine Biosciences, Inc. Stock Price Chart
Coinbase Lost $400M. Your Crypto Isn't Safe on Exchanges.
Stop trusting exchanges. Learn how to access Native Markets where YOU control your assets
Buy
60
NBIX
Neurocrine Biosciences, Inc.
Last Price:
$135.93
Seasonality Move:
-2.87%
7 Day Trial
ALL ACCESS PASS
$
7
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBIX is experiencing buying pressure, which is a positive indicator for future bullish movement.
Neurocrine Biosciences, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 134.16 | Buy |
| 20-day SMA: | 138.26 | Sell |
| 50-day SMA: | 144.1 | Sell |
| 200-day SMA: | 132.7 | Buy |
| 8-day EMA: | 135.43 | Buy |
| 20-day EMA: | 138.03 | Sell |
| 50-day EMA: | 141.42 | Sell |
| 200-day EMA: | 136.54 | Buy |
Neurocrine Biosciences, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -3.07 | Sell |
| Relative Strength Index (14 RSI): | 46.11 | Sell |
| Chaikin Money Flow: | 593975 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (134.45 - 144.75) | Sell |
| Bollinger Bands (100): | (137.09 - 149.03) | Sell |
Neurocrine Biosciences, Inc. Technical Analysis
| Jan 8 | Jan 9 | Jan 12 | Jan 13 | Jan 14 | Jan 15 | Jan 16 | Jan 20 | Jan 21 | Jan 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan | ||||||||||
| 08 | 09 | 12 | 13 | 14 | 15 | 16 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Neurocrine Biosciences, Inc. Stock
Is Neurocrine Biosciences, Inc. Stock a Buy?
-
Neurocrine Biosciences, Inc. share price is 137.37 while NBIX 8-day simple moving average is 134.16, which is a Buy signal.
-
The stock price of NBIX is 137.37 while Neurocrine Biosciences, Inc. 20-day SMA is 138.26, which makes it a Sell.
-
Neurocrine Biosciences, Inc. 50-day simple moving average is 144.10 while NBIX share price is 137.37, making it a Sell technically.
-
NBIX stock price is 137.37 and Neurocrine Biosciences, Inc. 200-day simple moving average is 132.70, creating a Buy signal.
NBIX Technical Analysis vs Fundamental Analysis
Buy
60
Neurocrine Biosciences, Inc. (NBIX)
is a Buy
Is Neurocrine Biosciences, Inc. a Buy or a Sell?
-
Neurocrine Biosciences, Inc. stock is rated a BuyThe current Neurocrine Biosciences, Inc. [NBIX] share price is $137.37. The Score for NBIX is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
Neurocrine Biosciences, Inc. Stock Info
Market Cap:
13.7B
Price in USD:
137.37
Share Volume:
800.6K
Neurocrine Biosciences, Inc. 52-Week Range
52-Week High:
160.18
52-Week Low:
84.23
Buy
60
Neurocrine Biosciences, Inc. (NBIX)
is a Buy
Neurocrine Biosciences, Inc. Share Price Forecast
-
What is the Neurocrine Biosciences, Inc. stock price today?The Neurocrine Biosciences, Inc. stock price is 137.37 USD today.
-
Will NBIX stock go up or go down?Neurocrine Biosciences, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Neurocrine Biosciences, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Neurocrine Biosciences, Inc. is not overvalued.
Is Neurocrine Biosciences, Inc. Stock a Buy?
-
Neurocrine Biosciences, Inc. share price is 137.37 while NBIX 8-day exponential moving average is 135.43, which is a Buy signal.
-
The stock price of NBIX is 137.37 while Neurocrine Biosciences, Inc. 20-day EMA is 138.03, which makes it a Sell.
-
Neurocrine Biosciences, Inc. 50-day exponential moving average is 141.42 while NBIX share price is 137.37, making it a Sell technically.
-
NBIX stock price is 137.37 and Neurocrine Biosciences, Inc. 200-day simple moving average is 136.54, creating a Buy signal.
Fundamental Analysis of Neurocrine Biosciences, Inc.
Is Neurocrine Biosciences, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.36 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.25 per share, and an increase next year of $1.35 per share.
Technical Analysis of Neurocrine Biosciences, Inc.
Should I short Neurocrine Biosciences, Inc. stock?
-
NBIX Moving Average Covergence Divergence (MACD) indicator is -3.07, suggesting Neurocrine Biosciences, Inc. is a Sell
-
Neurocrine Biosciences, Inc. Relative Strength Index (RSI) is 46.11, which suggest Neurocrine Biosciences, Inc. is oversold
-
The Bollinger Bands (25) for Neurocrine Biosciences, Inc. is (134.45 - 144.75), which suggest Neurocrine Biosciences, Inc. is a Sell
-
The Bollinger Bands (100) for Neurocrine Biosciences, Inc. is (137.09 - 149.03), which suggest Neurocrine Biosciences, Inc. is a Sell
* Neurocrine Biosciences, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.